SidaGhanaV1, PubMed, Checkpoint, bibRecord, 000194

Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.

Identifieur interne : 000194 ( PubMed/Checkpoint ); précédent : 000193; suivant : 000195

Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.

Auteurs : Verner N. Orish [Ghana] ; Onyekachi S. Onyeabor [États-Unis] ; Johnson N. Boampong [Ghana] ; Richmond Afoakwah [Ghana] ; Ekene Nwaefuna [Ghana] ; Samuel Acquah [Ghana] ; Adekunle O. Sanyaolu ; Nnaemeka C. Iriemenam [Nigeria]

Source :

African health sciences [ 1729-0503 ] ; 2015.

RBID : pubmed:26958008

Descripteurs français

English descriptors

KwdEn :
- Adolescent, Adult, Antimalarials (therapeutic use), Cross-Sectional Studies, Dose-Response Relationship, Drug, Drug Combinations, Female, Ghana (epidemiology), Humans, Malaria (epidemiology), Malaria (prevention & control), Pregnancy, Pregnancy Complications, Parasitic (epidemiology), Pregnancy Complications, Parasitic (prevention & control), Prenatal Care, Pyrimethamine (therapeutic use), Regression Analysis, Socioeconomic Factors, Sulfadoxine (therapeutic use), Treatment Outcome.
MESH :
- chemical , therapeutic use : Antimalarials, Pyrimethamine, Sulfadoxine.
- epidemiology : Ghana, Malaria, Pregnancy Complications, Parasitic.
- prevention & control : Malaria, Pregnancy Complications, Parasitic.
- Adolescent, Adult, Cross-Sectional Studies, Dose-Response Relationship, Drug, Drug Combinations, Female, Humans, Pregnancy, Prenatal Care, Regression Analysis, Socioeconomic Factors, Treatment Outcome.

Abstract

Intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) has been adopted as policy by most countries in sub-Saharan Africa. This cross-sectional study assessed the prevalence of IPTp-SP usage for prevention of malaria among pregnant women as well as evaluated factors associated with IPTp-SP use during pregnancy in Sekondi-Takoradi region of Ghana.

DOI: 10.4314/ahs.v15i4.6
PubMed: 26958008

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000223
to stream PubMed, to step Curation: 000223

Links to Exploration step

pubmed:26958008

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.</title>
<author><name sortKey="Orish, Verner N" sort="Orish, Verner N" uniqKey="Orish V" first="Verner N" last="Orish">Verner N. Orish</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Effia-Nkwanta Regional Hospital Sekondi-Takoradi, Sekondi P. O. Box 229, Western Region, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Internal Medicine, Effia-Nkwanta Regional Hospital Sekondi-Takoradi, Sekondi P. O. Box 229, Western Region</wicri:regionArea>
<wicri:noRegion>Western Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Onyeabor, Onyekachi S" sort="Onyeabor, Onyekachi S" uniqKey="Onyeabor O" first="Onyekachi S" last="Onyeabor">Onyekachi S. Onyeabor</name>
<affiliation wicri:level="2"><nlm:affiliation>The Satcher Health Leadership Institute, Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, Georgia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Satcher Health Leadership Institute, Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Boampong, Johnson N" sort="Boampong, Johnson N" uniqKey="Boampong J" first="Johnson N" last="Boampong">Johnson N. Boampong</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region</wicri:regionArea>
<wicri:noRegion>Central Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Afoakwah, Richmond" sort="Afoakwah, Richmond" uniqKey="Afoakwah R" first="Richmond" last="Afoakwah">Richmond Afoakwah</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region</wicri:regionArea>
<wicri:noRegion>Central Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nwaefuna, Ekene" sort="Nwaefuna, Ekene" uniqKey="Nwaefuna E" first="Ekene" last="Nwaefuna">Ekene Nwaefuna</name>
<affiliation wicri:level="3"><nlm:affiliation>Biotechnology and Nuclear Agriculture Research Institute, Atomic Energy Commission, Accra, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Biotechnology and Nuclear Agriculture Research Institute, Atomic Energy Commission, Accra</wicri:regionArea>
<placeName><settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Acquah, Samuel" sort="Acquah, Samuel" uniqKey="Acquah S" first="Samuel" last="Acquah">Samuel Acquah</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Biochemistry, School of Medical Sciences, University of Cape Coast, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Medical Biochemistry, School of Medical Sciences, University of Cape Coast</wicri:regionArea>
<wicri:noRegion>University of Cape Coast</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sanyaolu, Adekunle O" sort="Sanyaolu, Adekunle O" uniqKey="Sanyaolu A" first="Adekunle O" last="Sanyaolu">Adekunle O. Sanyaolu</name>
<affiliation><nlm:affiliation>Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, PMB 12003 Lagos, Nigeria; Saint James School of Medicine, Anguilla, BWI.</nlm:affiliation>
<wicri:noCountry code="subField">BWI</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Iriemenam, Nnaemeka C" sort="Iriemenam, Nnaemeka C" uniqKey="Iriemenam N" first="Nnaemeka C" last="Iriemenam">Nnaemeka C. Iriemenam</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, PMB 12003 Lagos, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, PMB 12003 Lagos</wicri:regionArea>
<wicri:noRegion>PMB 12003 Lagos</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26958008</idno>
<idno type="pmid">26958008</idno>
<idno type="doi">10.4314/ahs.v15i4.6</idno>
<idno type="wicri:Area/PubMed/Corpus">000223</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000223</idno>
<idno type="wicri:Area/PubMed/Curation">000223</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000223</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000223</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000223</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.</title>
<author><name sortKey="Orish, Verner N" sort="Orish, Verner N" uniqKey="Orish V" first="Verner N" last="Orish">Verner N. Orish</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Effia-Nkwanta Regional Hospital Sekondi-Takoradi, Sekondi P. O. Box 229, Western Region, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Internal Medicine, Effia-Nkwanta Regional Hospital Sekondi-Takoradi, Sekondi P. O. Box 229, Western Region</wicri:regionArea>
<wicri:noRegion>Western Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Onyeabor, Onyekachi S" sort="Onyeabor, Onyekachi S" uniqKey="Onyeabor O" first="Onyekachi S" last="Onyeabor">Onyekachi S. Onyeabor</name>
<affiliation wicri:level="2"><nlm:affiliation>The Satcher Health Leadership Institute, Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, Georgia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Satcher Health Leadership Institute, Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Boampong, Johnson N" sort="Boampong, Johnson N" uniqKey="Boampong J" first="Johnson N" last="Boampong">Johnson N. Boampong</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region</wicri:regionArea>
<wicri:noRegion>Central Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Afoakwah, Richmond" sort="Afoakwah, Richmond" uniqKey="Afoakwah R" first="Richmond" last="Afoakwah">Richmond Afoakwah</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region</wicri:regionArea>
<wicri:noRegion>Central Region</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nwaefuna, Ekene" sort="Nwaefuna, Ekene" uniqKey="Nwaefuna E" first="Ekene" last="Nwaefuna">Ekene Nwaefuna</name>
<affiliation wicri:level="3"><nlm:affiliation>Biotechnology and Nuclear Agriculture Research Institute, Atomic Energy Commission, Accra, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Biotechnology and Nuclear Agriculture Research Institute, Atomic Energy Commission, Accra</wicri:regionArea>
<placeName><settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Acquah, Samuel" sort="Acquah, Samuel" uniqKey="Acquah S" first="Samuel" last="Acquah">Samuel Acquah</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Biochemistry, School of Medical Sciences, University of Cape Coast, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Medical Biochemistry, School of Medical Sciences, University of Cape Coast</wicri:regionArea>
<wicri:noRegion>University of Cape Coast</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sanyaolu, Adekunle O" sort="Sanyaolu, Adekunle O" uniqKey="Sanyaolu A" first="Adekunle O" last="Sanyaolu">Adekunle O. Sanyaolu</name>
<affiliation><nlm:affiliation>Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, PMB 12003 Lagos, Nigeria; Saint James School of Medicine, Anguilla, BWI.</nlm:affiliation>
<wicri:noCountry code="subField">BWI</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Iriemenam, Nnaemeka C" sort="Iriemenam, Nnaemeka C" uniqKey="Iriemenam N" first="Nnaemeka C" last="Iriemenam">Nnaemeka C. Iriemenam</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, PMB 12003 Lagos, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, PMB 12003 Lagos</wicri:regionArea>
<wicri:noRegion>PMB 12003 Lagos</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">African health sciences</title>
<idno type="eISSN">1729-0503</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Antimalarials (therapeutic use)</term>
<term>Cross-Sectional Studies</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Combinations</term>
<term>Female</term>
<term>Ghana (epidemiology)</term>
<term>Humans</term>
<term>Malaria (epidemiology)</term>
<term>Malaria (prevention & control)</term>
<term>Pregnancy</term>
<term>Pregnancy Complications, Parasitic (epidemiology)</term>
<term>Pregnancy Complications, Parasitic (prevention & control)</term>
<term>Prenatal Care</term>
<term>Pyrimethamine (therapeutic use)</term>
<term>Regression Analysis</term>
<term>Socioeconomic Factors</term>
<term>Sulfadoxine (therapeutic use)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Analyse de régression</term>
<term>Antipaludiques (usage thérapeutique)</term>
<term>Association médicamenteuse</term>
<term>Complications parasitaires de la grossesse ()</term>
<term>Complications parasitaires de la grossesse (épidémiologie)</term>
<term>Facteurs socioéconomiques</term>
<term>Femelle</term>
<term>Ghana (épidémiologie)</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Paludisme ()</term>
<term>Paludisme (épidémiologie)</term>
<term>Prise en charge prénatale</term>
<term>Pyriméthamine (usage thérapeutique)</term>
<term>Relation dose-effet des médicaments</term>
<term>Résultat thérapeutique</term>
<term>Sulfadoxine (usage thérapeutique)</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antimalarials</term>
<term>Pyrimethamine</term>
<term>Sulfadoxine</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Ghana</term>
<term>Malaria</term>
<term>Pregnancy Complications, Parasitic</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Malaria</term>
<term>Pregnancy Complications, Parasitic</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antipaludiques</term>
<term>Pyriméthamine</term>
<term>Sulfadoxine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Complications parasitaires de la grossesse</term>
<term>Ghana</term>
<term>Paludisme</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Cross-Sectional Studies</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Combinations</term>
<term>Female</term>
<term>Humans</term>
<term>Pregnancy</term>
<term>Prenatal Care</term>
<term>Regression Analysis</term>
<term>Socioeconomic Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Analyse de régression</term>
<term>Association médicamenteuse</term>
<term>Complications parasitaires de la grossesse</term>
<term>Facteurs socioéconomiques</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Paludisme</term>
<term>Prise en charge prénatale</term>
<term>Relation dose-effet des médicaments</term>
<term>Résultat thérapeutique</term>
<term>Études transversales</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) has been adopted as policy by most countries in sub-Saharan Africa. This cross-sectional study assessed the prevalence of IPTp-SP usage for prevention of malaria among pregnant women as well as evaluated factors associated with IPTp-SP use during pregnancy in Sekondi-Takoradi region of Ghana.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26958008</PMID>
<DateCreated><Year>2016</Year>
<Month>03</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>03</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>03</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1729-0503</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>15</Volume>
<Issue>4</Issue>
<PubDate><Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>African health sciences</Title>
<ISOAbbreviation>Afr Health Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.</ArticleTitle>
<Pagination><MedlinePgn>1087-96</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4314/ahs.v15i4.6</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) has been adopted as policy by most countries in sub-Saharan Africa. This cross-sectional study assessed the prevalence of IPTp-SP usage for prevention of malaria among pregnant women as well as evaluated factors associated with IPTp-SP use during pregnancy in Sekondi-Takoradi region of Ghana.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Pregnant women attending their antenatal-care with either clinical/ultrasound evidence of pregnancy were recruited. Venous blood was screened for malaria using RAPID response antibody kit and Giemsa staining. Haemoglobin estimations were done by cyanmethemoglobin method while Human Immunodeficiency Virus (HIV) screening was performed by the national diagnostic algorithm of two rapid antibody test and western blot confirmation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 754 consented pregnant women interviewed in this study, 57.8% had received IPTp-SP while 42.2% had not at their first contact with the study personnel. Furthermore, 18.6% (81/436) of those that received IPTp-SP were malaria positive while 81.4% (355/436) were malaria negative. The results also indicated that 47.7% (51/107) of the pregnant women in their third trimester who were meant to have received at least two-doses of SP had received ≥2 doses while 35.5% (38/107) had received 1 dose. In multivariable logistic regression analysis, pregnant women in their third trimester who received ≥2 doses of SP showed decreased likelihoods of malaria (adjusted OR, 0.042; 95% CI, 0.003-0.51; P = 0.013).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">IPTp-SP usage among pregnant women in Sekondi-Takoradi reduces malaria and its use for malaria prevention should be strengthened with proper dosage completion and coverage.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Orish</LastName>
<ForeName>Verner N</ForeName>
<Initials>VN</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Effia-Nkwanta Regional Hospital Sekondi-Takoradi, Sekondi P. O. Box 229, Western Region, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Onyeabor</LastName>
<ForeName>Onyekachi S</ForeName>
<Initials>OS</Initials>
<AffiliationInfo><Affiliation>The Satcher Health Leadership Institute, Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, Georgia, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Boampong</LastName>
<ForeName>Johnson N</ForeName>
<Initials>JN</Initials>
<AffiliationInfo><Affiliation>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Afoakwah</LastName>
<ForeName>Richmond</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Human Biology, University of Cape Coast, Cape Coast, Central Region, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nwaefuna</LastName>
<ForeName>Ekene</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Biotechnology and Nuclear Agriculture Research Institute, Atomic Energy Commission, Accra, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Acquah</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Medical Biochemistry, School of Medical Sciences, University of Cape Coast, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sanyaolu</LastName>
<ForeName>Adekunle O</ForeName>
<Initials>AO</Initials>
<AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, PMB 12003 Lagos, Nigeria; Saint James School of Medicine, Anguilla, BWI.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Iriemenam</LastName>
<ForeName>Nnaemeka C</ForeName>
<Initials>NC</Initials>
<AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Idi-araba, PMB 12003 Lagos, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Uganda</Country>
<MedlineTA>Afr Health Sci</MedlineTA>
<NlmUniqueID>101149451</NlmUniqueID>
<ISSNLinking>1680-6905</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>37338-39-9</RegistryNumber>
<NameOfSubstance UI="C001205">fanasil, pyrimethamine drug combination</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>88463U4SM5</RegistryNumber>
<NameOfSubstance UI="D013413">Sulfadoxine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Z3614QOX8W</RegistryNumber>
<NameOfSubstance UI="D011739">Pyrimethamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>BJOG. 2011 Jan;118(2):123-35</RefSource>
<PMID Version="1">21159117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Gynaecol Obstet. 2011 Jan;112(1):30-3</RefSource>
<PMID Version="1">20947080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hematol Oncol Clin North Am. 2011 Apr;25(2):241-59, vii</RefSource>
<PMID Version="1">21444028</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Matern Child Health J. 2011 May;15(4):542-52</RefSource>
<PMID Version="1">20425139</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2011 Jul;85(1):12-21</RefSource>
<PMID Version="1">21734118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2011;4:108</RefSource>
<PMID Version="1">21679439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2011 Aug 1;53(3):215-23</RefSource>
<PMID Version="1">21765069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2011 Aug;85(2):214-20</RefSource>
<PMID Version="1">21813837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2011 Sep;85(3):414-20</RefSource>
<PMID Version="1">21896797</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Malar J. 2011;10:385</RefSource>
<PMID Version="1">22206597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2012 Sep;123(3):244-8</RefSource>
<PMID Version="1">22673039</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2012 Oct;55(7):1025-6; author reply 1026-7</RefSource>
<PMID Version="1">22715177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2012 Oct;55(8):1103-5</RefSource>
<PMID Version="1">22767650</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Gynaecol Obstet. 2013 Mar;120(3):236-9</RefSource>
<PMID Version="1">23219288</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2013 Feb 13;309(6):594-604</RefSource>
<PMID Version="1">23403684</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2013 Sep;208(6):907-16</RefSource>
<PMID Version="1">23801600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):28-35</RefSource>
<PMID Version="1">11425175</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):45-56</RefSource>
<PMID Version="1">11425177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Afr Health. 1997 Jan;19(2):19-20</RefSource>
<PMID Version="1">12292301</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Indian J Pediatr. 2003 Jan;70(1):25-8</RefSource>
<PMID Version="1">12619948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):35-40</RefSource>
<PMID Version="1">15331817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):41-54</RefSource>
<PMID Version="1">15331818</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2004 Oct;9(10):1066-73</RefSource>
<PMID Version="1">15482398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Obstet Gynaecol. 1998 Apr;105(4):385-90</RefSource>
<PMID Version="1">9609262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1999 Mar;93(2):119-33</RefSource>
<PMID Version="1">10474637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2005 Sep;10(9):901-8</RefSource>
<PMID Version="1">16135198</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2007 Feb;7(2):93-104</RefSource>
<PMID Version="1">17251080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Drug Saf. 2007;30(6):481-501</RefSource>
<PMID Version="1">17536875</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Malar J. 2007;6:88</RefSource>
<PMID Version="1">17617910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BJOG. 2007 Oct;114(10):1222-31</RefSource>
<PMID Version="1">17666098</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitol Res. 2007 Nov;101(6):1463-9</RefSource>
<PMID Version="1">17874326</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2007 Dec 1;196(11):1577-84</RefSource>
<PMID Version="1">18008240</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Malar J. 2007;6:144</RefSource>
<PMID Version="1">17996048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2008 Nov 15;198(10):1545-9</RefSource>
<PMID Version="1">18834303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Malar J. 2008;7:234</RefSource>
<PMID Version="1">18992140</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2009 Feb;14(2):174-82</RefSource>
<PMID Version="1">19171009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2009 Oct;112(1):54-8</RefSource>
<PMID Version="1">19539589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2010 Jun;104(6):416-22</RefSource>
<PMID Version="1">20207387</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2010 Aug;104(8):536-40</RefSource>
<PMID Version="1">20227739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Malar J. 2010;9:247</RefSource>
<PMID Version="1">20799995</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Vector Borne Dis. 2011 Mar;48(1):12-7</RefSource>
<PMID Version="1">21406732</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N">Ghana</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008288" MajorTopicYN="N">Malaria</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015597" MajorTopicYN="N">Pregnancy Complications, Parasitic</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011295" MajorTopicYN="N">Prenatal Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011739" MajorTopicYN="N">Pyrimethamine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013413" MajorTopicYN="N">Sulfadoxine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4765396</OtherID>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ghana</Keyword>
<Keyword MajorTopicYN="N">IPTp-SP</Keyword>
<Keyword MajorTopicYN="N">Malaria in pregnancy</Keyword>
<Keyword MajorTopicYN="N">anaemia</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>3</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>3</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>3</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26958008</ArticleId>
<ArticleId IdType="doi">10.4314/ahs.v15i4.6</ArticleId>
<ArticleId IdType="pii">jAFHS.v15.i4.pg1087</ArticleId>
<ArticleId IdType="pmc">PMC4765396</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Ghana</li>
<li>Nigeria</li>
<li>États-Unis</li>
</country>
<region><li>Géorgie (États-Unis)</li>
<li>Région du Grand Accra</li>
</region>
<settlement><li>Accra</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Sanyaolu, Adekunle O" sort="Sanyaolu, Adekunle O" uniqKey="Sanyaolu A" first="Adekunle O" last="Sanyaolu">Adekunle O. Sanyaolu</name>
</noCountry>
<country name="Ghana"><noRegion><name sortKey="Orish, Verner N" sort="Orish, Verner N" uniqKey="Orish V" first="Verner N" last="Orish">Verner N. Orish</name>
</noRegion>
<name sortKey="Acquah, Samuel" sort="Acquah, Samuel" uniqKey="Acquah S" first="Samuel" last="Acquah">Samuel Acquah</name>
<name sortKey="Afoakwah, Richmond" sort="Afoakwah, Richmond" uniqKey="Afoakwah R" first="Richmond" last="Afoakwah">Richmond Afoakwah</name>
<name sortKey="Boampong, Johnson N" sort="Boampong, Johnson N" uniqKey="Boampong J" first="Johnson N" last="Boampong">Johnson N. Boampong</name>
<name sortKey="Nwaefuna, Ekene" sort="Nwaefuna, Ekene" uniqKey="Nwaefuna E" first="Ekene" last="Nwaefuna">Ekene Nwaefuna</name>
</country>
<country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Onyeabor, Onyekachi S" sort="Onyeabor, Onyekachi S" uniqKey="Onyeabor O" first="Onyekachi S" last="Onyeabor">Onyekachi S. Onyeabor</name>
</region>
</country>
<country name="Nigeria"><noRegion><name sortKey="Iriemenam, Nnaemeka C" sort="Iriemenam, Nnaemeka C" uniqKey="Iriemenam N" first="Nnaemeka C" last="Iriemenam">Nnaemeka C. Iriemenam</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000194 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000194 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:26958008
   |texte=   Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:26958008" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaGhanaV1

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA au Ghana (serveur d'exploration)

Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.

Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki